David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.35% |
| 2 | Healthcare | 8.99% |
| 3 | Financials | 7.94% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Corebridge Financial
CRBG
$14.5B
| $900K | ﹤0.01% |
+44,857
| New | +$947K |
|
3377
Cato Corp
CATO
$55.3M
| $899K | ﹤0.01% |
+96,376
| New | +$986K |
|
3378
The Bancorp
TBBK
$2.7B
| $894K | ﹤0.01% |
31,502
-12,083
| -28% | -$334K |
|
|
GBIO
3379
DELISTED
Generation Bio
GBIO
| $892K | ﹤0.01% |
22,685
+943
| +4% | +$49.5K |
|
3380
Fox Factory Holding Corp
FOXF
$885M
| $891K | ﹤0.01% |
9,768
-4,709
| -33% | -$438K |
|
3381
Lumen
LUMN
$6.28B
| $890K | ﹤0.01% |
170,585
-239,624
| -58% | -$1.47M |
|
3382
First Commonwealth Financial
FCF
$2.1B
| $889K | ﹤0.01% |
63,652
-24,852
| -28% | -$350K |
|
|
NXH
3383
PUT
Neighborhood Intelligence Inc
NXH
$383M
| $889K | ﹤0.01% |
50,490
-2,750
| -5% | -$59.1K |
|
|
PPLI
3384
CALL
People Inc
PPLI
$2.92B
| $888K | ﹤0.01% |
24,380
-9,874
| -29% | -$391K |
|
3385
Adaptive Biotechnologies
ADPT
$4.18B
| $888K | ﹤0.01% |
116,182
+57,498
| +98% | +$447K |
|
3386
Pilgrim's Pride
PPC
$7.45B
| $887K | ﹤0.01% |
37,391
-58,355
| -61% | -$1.39M |
|
|
BORR
3387
Borr Drilling
BORR
$1.36B
| $887K | ﹤0.01% |
+178,494
| New | +$794K |
|
|
CNSL
3388
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $883K | ﹤0.01% |
246,611
+119,432
| +94% | +$530K |
|
3389
Arbor Realty Trust
ABR
$944M
| $882K | ﹤0.01% |
66,873
-67,891
| -50% | -$922K |
|
|
BIG
3390
CALL
DELISTED
Big Lots, Inc.
BIG
| $882K | ﹤0.01% |
60,000
| – | – |
|
|
HLTH
3391
DELISTED
Cue Health Inc. Common Stock
HLTH
| $879K | ﹤0.01% |
424,678
-100,248
| -19% | -$317K |
|
|
WRK
3392
PUT
DELISTED
WestRock Company
WRK
| $879K | ﹤0.01% |
25,000
| – | – |
|
3393
PUT
Blink Charging
BLNK
$85.9M
| $878K | ﹤0.01% |
80,000
| – | – |
|
3394
Schrodinger
SDGR
$1.46B
| $869K | ﹤0.01% |
+46,483
| New | +$964K |
|
3395
Emcor
EME
$33.7B
| $867K | ﹤0.01% |
5,857
-7,015
| -54% | -$996K |
|
|
AMK
3396
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $867K | ﹤0.01% |
+37,684
| New | +$830K |
|
|
JBIO
3397
Jade Biosciences
JBIO
$1.36B
| $864K | ﹤0.01% |
843
-137
| -14% | -$99.5K |
|
3398
PUT
Acuity Brands
AYI
$10.2B
| $861K | ﹤0.01% |
5,200
| – | – |
|
3399
Old Republic International
ORI
$10.2B
| $860K | ﹤0.01% |
35,598
+6,123
| +21% | +$144K |
|
3400
Hackett Group
HCKT
$273M
| $859K | ﹤0.01% |
42,173
-12,364
| -23% | -$261K |
|
Similar funds
David Shaw's Q4 2022 Portfolio in Review
As of Q4 2022, David Shaw held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
David Shaw's Q4 2022 filing shows 475 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- David Shaw's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- David Shaw added most to Tesla in Q4 2022, an estimated $826M increase.
- David Shaw's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- David Shaw fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- David Shaw's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- David Shaw opened 475 new positions and closed 783 in Q4 2022.
- David Shaw's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.